InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M
Source: SeekingAlpha
2025-09-23 08:35:48 ET
More on InMed Pharmaceuticals
- InMed Pharmaceuticals announces $5M private placement
- Financial information for InMed Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M
InMed Pharmaceuticals Inc.
NASDAQ: INM
INM Trading
123.81% G/L:
$1.555 Last:
73,877,530 Volume:
$1.79 Open:
